Kellerin from Ferula sinkiangensis exerts neuroprotective effects after focal cerebral ischemia in rats by inhibiting microglia-mediated inflammatory responses
Yan Mi,Kun Jiao,Ji-Kai Xu,Kun Wei,Jing-Yu Liu,Qing-Qi Meng,Ting-Ting Guo,Xue-Ni Zhang,Di Zhou,De-Gang Qing,Yu Sun,Ning Li,Yue Hou,Ji-kai Xu,Jing-yu Liu,Qing-qi Meng,Ting-ting Guo,Xue-ni Zhang,De-gang Qing
DOI: https://doi.org/10.1016/j.jep.2020.113718
IF: 5.195
2021-04-01
Journal of Ethnopharmacology
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Ethnopharmacological relevance</h3><p><em>Ferula sinkiangensis K. M. Shen</em> is a traditional Chinese medicine that has a variety of pharmacological properties relevant to neurological disorders and inflammations. Kellerin, a novel compound extracted from <em>Ferula sinkiangensis</em>, exerts a strong anti-neuroinflammatory effect by inhibiting microglial activation. Microglial activation plays a vital role in ischemia-induced brain injury. However, the potential therapeutic effect of kellerin on focal cerebral ischemia is still unknown.</p><p><strong><em>Aim of the study</em></strong>: To explore the effect of kellerin on cerebral ischemia and clarify its possible mechanisms,we applied the middle cerebral artery occlusion (MCAO) model and the LPS-activated microglia model in our study.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Materials and methods</h3><p>Neurological outcome was examined according to a 4-tiered grading system. Brain infarct size was measured using TTC staining. Brain edema was calculated using the wet weight minus dry weight method. Neuron damage and microglial activation were observed by immunofluorescence in MCAO model in rats In <em>in vitro</em> studies<em>,</em> microglial activation was examined by flow cytometry and the viability of neuronal cells cultured in microglia-conditioned medium was measured using MTT assay. The levels of pro-inflammatory cytokines were measured by qRT-PCR and ELISA. The proteins involved in NF-κB signaling pathway were determined by western blot. Intracellular ROS was examined using DCFH-DA method and NADPH oxidase activity was measured using the NBT assay.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>We found that kellerin improved neurological outcome, reduced brain infarct size and decreased brain edema in MCAO model in rats. Under the pathologic conditions of focal cerebral ischemia, kellerin alleviated neuron damage and inhibited microglial activation. Moreover, in <em>in vitro</em> studies of LPS-stimulated BV2 cells kellerin protected neuronal cells from being damaged by inhibiting microglial activation. Kellerin also reduced the levels of pro-inflammatory cytokines, suppressed the NF-κB signaling pathway, and decreased ROS generation and NADPH oxidase activity.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>Our discoveries reveal that the neuroprotective effects of kellerin may largely depend on its inhibitory effect on microglial activation. This suggests that kellerin could serve as a novel anti-inflammatory agent which may have therapeutic effects in ischemic stroke.</p>
pharmacology & pharmacy,chemistry, medicinal,integrative & complementary medicine,plant sciences